Zomedica Pharmaceuticals Corphares (NYSEAMERICAN:ZOM) Sellers Increased Their Shorts By 17.49%

June 29, 2018 - By Sarah Holford

Change of 17.49% for Zomedica Pharmaceuticals Corphares (NYSEAMERICAN:ZOM)’s shorted shares was recorded. In June was announced ZOM’s total 52,400 shorted shares by FINRA. The 44,600 previous shares are up with 17.49%. With Average volume 13,200, ZOM’s former position will take 4 days to restore. 0.24% is Zomedica Pharmaceuticals Corphares float short.

Ticker’s shares touched $2.25 during the last trading session after 0.90% change.Currently Zomedica Pharmaceuticals Corp. is after 0.00% change in last June 29, 2017. ZOM has 2,574 shares volume. ZOM underperformed by 12.57% the S&P 500.

Zomedica Pharmaceuticals Corp. operates as a veterinary pharmaceutical firm in the United States.The firm is worth $189.46 million. It focuses on the discovery, development, and commercialization of drugs, novel drug delivery systems, devices, and diagnostics for the health and wellness of companion animals, such as canine, feline, and equine.Currently it has negative earnings. The firm has a research collaboration agreement with Celsee Diagnostics, Inc. to test the feasibility of Celsee's liquid biopsy technology for veterinary application as a canine cancer diagnostics.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.